AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

CNMD · NYSE · Medical - Devices

CONMED (CNMD)

Makes surgical devices for orthopedic and minimally invasive general procedures.

$46.06

vs last close+1.37 (+3.07%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	305	327	312	332	317	346	319	343	339	373	317	343
Cost of revenue	137	145	140	148	138	148	152	163	181	160	134	146
Gross profit	168	182	172	184	179	198	168	181	158	213	183	197
	138	132	137	137	113	146	156	139	139	146	158	161
Research & development	12	14	14	14	14	13	13	14	14	15	16	16
Selling, general & administrative	125	118	123	123	100	133	143	125	125	132	142	146
Operating income	30	50	35	47	66	52	11	42	19	67	25	36
	−10	−10	−10	−10	−9	−9	−4	−12	−15	−38	−7	−5
Interest expense	10	10	10	10	9	9	8	8	8	7	7	8
Other non-operating income	0	0	0	0	0	0	−4	4	8	30	0	−3
Income before tax	20	41	25	38	56	44	8	30	4	29	18	31
Income tax expense	4	8	6	8	7	10	2	8	1	13	5	8
Net income from continuing operations	16	33	20	30	49	34	6	21	3	17	14	23
Net income	16	33	20	30	49	34	6	21	3	17	14	23
EPS, basic	$0.52	$1.08	$0.64	$0.97	$1.59	$1.09	$0.19	$0.69	$0.09	$0.54	$0.45	$0.77
EPS, diluted	$0.50	$1.05	$0.63	$0.96	$1.57	$1.08	$0.19	$0.69	$0.09	$0.54	$0.45	$0.77
Weighted average shares, basic	31	31	31	31	31	31	31	31	31	31	31	30
Weighted average shares, diluted	32	32	31	31	31	31	31	31	31	31	31	30
EBITDA	43	68	53	65	84	71	29	51	25	55	38	61
Depreciation & amortization	13	18	18	18	18	18	13	13	13	19	13	22
EBIT	30	50	35	47	66	52	16	38	12	37	25	39